New treatments for localized prostate cancer. Urology. 2008;72(6 Suppl):S36–43. View ArticleMarberger M., Carroll P.R., Zelefsky M.J., Coleman J.A., Hricak H., Scardino P.T., Abenhaim L.L. New treatments for localized prostate cancer. Urology. 2008; 72 :S36–S43. doi: ...
In the realm of medical advancements, the treatment of prostate cancer, a significant health concern for middle-aged men, has seen remarkable progress. This article, tailored for students from elementary to high school, aims to educate you on the basics of prostate cancer, new therapies, and ho...
Prostate cancer is often an indolent disease, and delays in treatment up to 6 months do not seem to affect cancer-free survival. Inadequate pre-treatment assessment and uninformed shared decision-making can lead to decision regret and disparities in receipt of treatments. Time is on our side to...
Black patients with prostate cancer have historically been underrepresented in clinical trials, leading to insufficient data on the effectiveness and safety of new treatments for this group.1 In a phase II trial involving 100 patients with metastatic castration-resistant prostate cancer (mCRPC), 50 ...
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
To establish which genetic factors play a role in the development and progression of prostate cancer could help to determine who is at greatest risk, leading to early detection and/or developing new therapeutic treatments. Studies of genome-wide association (GWAS) are being designed with increasing...
Newly diagnosed prostate cancer patients with disease confined to the capsule have a number of alternative treatments like brachytherapy, ablation, cryoablation, Nanoknife, HIFU or Proton Beam Therapy available to them, not just Active Surveillance, surgery or radiotherapy; these alternatives are more wi...
Cancer Type Prostate Cancer Treatment and Symptom Management: Episode4 Video September 18, 2015 Your browser does not support the video tag. Related Videos How Five-Fraction SBRT Compares With Traditional Radiation in Prostate Cancer Using Clinical Trials to Advance Prostate Cancer Treatments ...
Prostate cancer is a major disease that threatens men’s health. Its rapid progression, easy metastasis, and late castration resistance have brought obstacles to treatment. It is necessary to find new effective anticancer methods. Ferroptosis is a novel
Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer. Here, we report broad expression of STEAP1 relative to prostate-specific membrane antigen (PSMA) in lethal metastatic